Your browser doesn't support javascript.
loading
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma.
Ferrarotto, Renata; Sousa, Luana G; Feng, Lei; Mott, Frank; Blumenschein, George; Altan, Mehmet; Bell, Diana; Bonini, Flavia; Li, Kaiyi; Marques-Piubelli, Mario L; Dal Lago, Eduardo A; Johnson, Jason J; Mitani, Yoshitsugu; Godoy, Myrna; Lee, Anna; Kupferman, Michael; Hanna, Ehab; Glisson, Bonnie S; Elamin, Yasir; El-Naggar, Adel.
Afiliación
  • Ferrarotto R; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sousa LG; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mott F; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Blumenschein G; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Altan M; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Bell D; Department of Pathology, City of Hope, Duarte, CA.
  • Bonini F; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Li K; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dal Lago EA; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Johnson JJ; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mitani Y; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Godoy M; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lee A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kupferman M; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hanna E; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Glisson BS; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Elamin Y; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • El-Naggar A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
J Clin Oncol ; 41(15): 2843-2851, 2023 05 20.
Article en En | MEDLINE | ID: mdl-36898078
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Adenoide Quístico Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Adenoide Quístico Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos